How GLP-1 drugs are driving U.S. obesity rates down to 36.4%

As GLP-1 drug use rises, obesity rates are falling across age groups, except among adults 65 and older, who report lower effectiveness, the poll found.

NewsBeagle is a discovery engine. We show the headline, a short source-supplied summary and clear attribution. The complete reporting remains with the publisher.